Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
239.20
+2.09 (0.88%)
Nov 20, 2024, 4:00 PM EST - Market closed

Company Description

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally.

The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.

It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands.

In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products.

Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum.

The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Penumbra, Inc.
Penumbra logo
Country United States
Founded 2004
IPO Date Sep 18, 2015
Industry Medical Devices
Sector Healthcare
Employees 4,200
CEO Adam Elsesser

Contact Details

Address:
One Penumbra Place
Alameda, California 94502
United States
Phone 510 748 3200
Website penumbrainc.com

Stock Details

Ticker Symbol PEN
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001321732
CUSIP Number 70975L107
ISIN Number US70975L1070
SIC Code 3841

Key Executives

Name Position
Dr. Arani Bose M.D. Co-Founder and Director
Maggie S. Yuen Chief Financial Officer
Lambert Shiu Chief Accounting Officer
Ben Sorci Executive Vice President of Operations
Pankaj Tiwari Executive Vice President and Chief Information Officer
Jee Hamlyn-Harris Investor Relations Officer
Ben Tompkins Executive Vice President of Development and Compliance
Shruthi Narayan Executive Vice President and GM of Interventional
Jason Richard Mills Executive Vice President of Strategy
Dr. James F. Benenati FSIR, M.D. Chief Medical Officer

Latest SEC Filings

Date Type Title
Nov 20, 2024 144 Filing
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Oct 30, 2024 10-Q Quarterly Report
Oct 30, 2024 8-K Current Report
Oct 2, 2024 144 Filing
Sep 4, 2024 144 Filing
Sep 3, 2024 144 Filing
Aug 22, 2024 144 Filing
Aug 13, 2024 8-K Current Report